Maintenance Notice

Due to necessary scheduled maintenance, the JMIR Publications website will be unavailable from Wednesday, July 01, 2020 at 8:00 PM to 10:00 PM EST. We apologize in advance for any inconvenience this may cause you.

Who will be affected?


Currently submitted to: Journal of Medical Internet Research

Date Submitted: Sep 29, 2020
Open Peer Review Period: Sep 29, 2020 - Oct 7, 2020
(closed for review but you can still tweet)

NOTE: This is an unreviewed Preprint

Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).

Peer-review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer-Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.

Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).

Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.

Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.

Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.

Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.

Development and validation of a candidemia risk prediction (CanDETEC) model among patients with malignancy

  • Junsang Yoo; 
  • Si-Ho Kim; 
  • Sujeong Hur; 
  • Juhyung Ha; 
  • Kyungmin Huh; 
  • Won Chul Cha



Appropriate empirical treatment for candidemia is associated with reduced mortality. However, timely diagnosis of candidemia for septic patients remains poor.


This study aimed to use machine learning algorithms to develop and validate a candidemia prediction model for cancer patients.


This single-center retrospective study used the cancer registry of a tertiary academic hospital. Adult patients with diagnosed malignancies from January 2010 to December 2018 were included. Our study outcome was the prediction of candidemia events. A stratified under-sampling method was used to extract control groups for algorithm learning. Multiple models were developed through a combination of four variable groups and five algorithms (auto-machine learning, deep neural network, gradient boosting, and logistic regression and random forest). The model with the highest area under the receiver operating characteristics (AUROC) was selected as the Candida species detection (CanDETEC) model and compared with the performance indexes of the candida score.


Among the 273,380 blood culture from 186,404 registered cancer patients, 501 candidemia events and 2000 controls were identified. The AUROC of the developed models varied from 0.771 to 0.889. The random forest model was selected CanDETEC model (AUROC = 0.889, 95% confidence interval: 0.888-0.889). It showed better performance than the candida score (AUROC = 0.677).


The CanDETEC model could predict candidemia in cancer patients with high discriminative power. This algorithm could be used for the timely diagnosis and appropriate empirical treatment of candidemia.


Please cite as:

Yoo J, Kim S, Hur S, Ha J, Huh K, Cha WC

Development and validation of a candidemia risk prediction (CanDETEC) model among patients with malignancy

JMIR Preprints. 29/09/2020:24651

DOI: 10.2196/preprints.24651


Download PDF

Request queued. Please wait while the file is being generated. It may take some time.

© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.